FEUTEL herbal combination to reduce HIV replication

Determination of the anti human immunodeficiency virus effect of Herbal Medicine, FEUTEL, on HIV infected Individuals

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016071929000N1

Enrollment

Registered

2016-07-30

Start date

2016-08-02

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV. Asymptomatic human immunodeficiency virus [HIV] infection status

Interventions

Feutel Herbal Medicine -10 mg/kg-Twice a day- 12 hrs intervals.

Treatment - Drugs

Feutel Herbal Medicine -10 mg/kg-Twice a day- 12 hrs intervals

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The main criteria for selection of patients: patients who were not taken any medications before and during the study. Patients will take the drug twice a day with an interval of 12 hours. Exclusion criteria: those who doesn’t follow the strategy or plan.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The evaluation of CD4. Timepoint: Twenty days before the intervention and after the intervention. Method of measurement: Flow cytometry.	—

Secondary

Measure	Time frame
The viral load. Timepoint: Twenty days before the intervention and after the intervention. Method of measurement: Real-Time PCR.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Hosseinpour

Shiraz University of Medical Sciences

p.afsar50@gmail.com+98 71 3233 3282

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026